Evaluation of IDH1 G105 Polymorphism in Iranian Acute Meyloid Leukemia patients

Publish Year: 1396
نوع سند: مقاله کنفرانسی
زبان: English
View: 532

نسخه کامل این Paper ارائه نشده است و در دسترس نمی باشد

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

ACPLMED19_060

تاریخ نمایه سازی: 20 آبان 1397

Abstract:

Aims : The aim of this study was to investigate the frequency and prognostic value of polymorphism rs11554137 in IDH1 gene in Iranian patients with AML.• Methods: Genotyping analysis was performed on AML patients using direct sequence analysis of PCR products amplified from IDH1 exon 4. The survival are presented in Kaplan Meier curves with log rank test. The level of statistical significance was considered as P < 0.05. • Result: IDH1 SNP rs11554137 was found in 6.25% of AML patients .There was no association between the SNP and patients age, sex, presenting WBC, FAB subtype, complete remission rate after induction therapy, disease free survival and overall survival.• Discussion: IDH1 SNP rs11554137 frequency in our population is lower than that in the other populations. Further study with a larger population is required to confirm the findings and to evaluate Impact of this polymorphism in relation to other genetic factors .

Keywords:

Authors

Shahrbano Rostami

Haematology-Oncology & Stem cell transplantation Research center, Tehran University of Medical Sciences

Habibaeh Ghadimi

Islamic Azad University, North of Tehran Branch, Tehran, Iran

Mitra Saleh

Islamic Azad University, North of Tehran Branch, Tehran, Iran

Bahram Chahardouli

Haematology-Oncology & Stem cell transplantation Research center, Tehran University of Medical Sciences